[1] YIT-LAI CHOW F S Mami Sogame. 13-Methylberberine, a berberine analogue with stronger anti-adipogenic effects on mouse 3T3-L1 cells[J]. Scientific Reports, 2016, 6 1. DOI:
10.1038/srep38129[2] WEIJIA KONG. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins[J]. Nature Medicine, 2004, 10 12: 1344-1351. DOI:
10.1038/nm1135[3] K IWASA . Antibacterial activity and structure-activity relationships of berberine analogs[J]. European Journal of Medicinal Chemistry, 1996, 31 6: Pages 469-478. DOI:
10.1016/0223-5234(96)85167-1[4] KINUKO IWASA. In Vitro Cytotoxicity of the Protoberberine-Type Alkaloids[J]. Journal of Natural Products , 2001, 64 7: 896-898. DOI:
10.1021/np000554f[5] DONG-UNG LEE . Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-α, iNOS, and IL-12 production in LPS-stimulated macrophages[J]. Life sciences, 2003, 73 11: Pages 1401-1412. DOI:
10.1016/s0024-3205(03)00435-1